210
Participants
Start Date
June 1, 2018
Primary Completion Date
March 17, 2023
Study Completion Date
June 30, 2023
Blood draw
Participation includes one visit for one blood draw per recruited patient. 10-20ml peripheral venous blood will be taken from the antecubital fossa. The DNA from the blood sample will then be extracted and resequenced for analysis.
Existing samples
Control DNA samples will be used that have been previously acquired in other studies.
Columbia University Medical Center, New York
Sicilian Epilepsy Network, Catania
Seattle Children's Hospital, Seattle
Hasbro Children's Hospital, Providence
Dr. Juan P. Garrahan Children's Hospital, Buenos Aires
Hospital for Sick Kids, Toronto
Aghia Sophia Children's Hospital of Athens, Athens
Commissione Genetica Lega Italiana contro l'Epilepssia, Roma
Hospital Mutua de Terrassa, Barcelona
Cardiff University School of Medicine, Cardiff
Guy's and St Thomas' NHS Foundation Trust, London
King's College Hospital NHS Foundation Trust, London
Swansea University College of Medicine, Swansea
King's College Hospital NHS Trust
OTHER
Guy's and St Thomas' NHS Foundation Trust
OTHER
Cardiff University
OTHER
The Hospital for Sick Children
OTHER
Hospital JP Garrahan
OTHER_GOV
Aghia Sophia Children's Hospital of Athens
OTHER
Hospital Mutua de Terrassa
OTHER
Seattle Children's Hospital
OTHER
Hasbro Children's Hospital
OTHER
Columbia University
OTHER
King's College London
OTHER